News

The FDA concluded that Perrigo’s products are therapeutically equivalent to Mallinckrodt’s Exalgo (hydromorphone HCI extended-release tablets) 8mg, 12mg and 16mg. According to the agency these products can be

CAP-1002 is being developed to treat advanced heart failure, including patients who were Class III or ambulatory Class IV with ejection fractions of 35% or below. A total

These standard chemotherapies include paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy. The approval was based on data from the pivotal

As part of the non-binding proposal, Perrigo shareholders would receive $205 in a combination of cash and Mylan stock for each Perrigo share. In a statement, Perrigo has

Designed to evaluate the safety and efficacy of ALX-0061, the trial is also aimed at obtaining parallel descriptive information concerning the efficacy and safety of administration of sc

The complete line of Bikini Ready’s women’s weight loss solutions includes Weight Loss Catalyst and Cleanse Cleanse nutritional supplements, as well as Yummy Nutrition Shakes. In 2014, Bikini

Tenofovir alafenamide fumarate (TAF) is a nucleotide reverse transcriptase inhibitor (NRTI) and a new prodrug of tenofovir. This is the company’s second NDA submitted to the FDA for

These tablets are the generic version of US-based pharmaceutical firm Warner Chilcott’s Generess Fe tablets. The US Food and Drug Administration (FDA) has also granted final approval for

The Phase II acne vulgaris trial will be conducted at about ten sites in Australia and New Zealand with Dr Lynda Spelman as the principal investigator. The trial